{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T17:06:01Z","timestamp":1769274361611,"version":"3.49.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,1,25]],"date-time":"2008-01-25T00:00:00Z","timestamp":1201219200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2008,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Although BCG vaccination is recommended in most countries of the world, little is known of the persistence of BCG-induced immune responses. As novel TB vaccines may be given to boost the immunity induced by neonatal BCG vaccination, evidence concerning the persistence of the BCG vaccine-induced response would help inform decisions about when such boosting would be most effective.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A randomised control study of UK adolescents was carried out to investigate persistence of BCG immune responses. Adolescents were tested for interferon-gamma (IFN-\u03b3) response to<jats:italic>Mycobacterium tuberculosis<\/jats:italic>purified protein derivative (M.tb PPD) in a whole blood assay before, 3 months, 12 months (n = 148) and 3 years (n = 19) after receiving teenage BCG vaccination or 14 years after receiving infant BCG vaccination (n = 16).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A gradual reduction in magnitude of response was evident from 3 months to 1 year and from 1 year to 3 years following teenage vaccination, but responses 3 years after vaccination were still on average 6 times higher than before vaccination among vaccinees. Some individuals (11\/86; 13%) failed to make a detectable antigen-specific response three months after vaccination, or lost the response after 1 (11\/86; 13%) or 3 (3\/19; 16%) years. IFN-\u03b3 response to Ag85 was measured in a subgroup of adolescents and appeared to be better maintained with no decline from 3 to 12 months. A smaller group of adolescents were tested 14 years after receiving infant BCG vaccination and 13\/16 (81%) made a detectable IFN-\u03b3 response to M.tb PPD 14 years after infant vaccination as compared to 6\/16 (38%) matched unvaccinated controls (p = 0.012); teenagers vaccinated in infancy were 19 times more likely to make an IFN-\u03b3 response of &gt; 500 pg\/ml than unvaccinated teenagers.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>BCG vaccination in infancy and adolescence induces immunological memory to mycobacterial antigens that is still present and measurable for at least 14 years in the majority of vaccinees, although the magnitude of the peripheral blood response wanes from 3 months to 12 months and from 12 months to 3 years post vaccination. The data presented here suggest that because of such waning in the response there may be scope for boosting anti-tuberculous immunity in BCG vaccinated children anytime from 3 months post-vaccination. This supports the prime boost strategies being employed for some new TB vaccines currently under development.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1471-2334-8-9","type":"journal-article","created":{"date-parts":[[2008,1,25]],"date-time":"2008-01-25T19:20:33Z","timestamp":1201288833000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Persistence of the immune response induced by BCG vaccination"],"prefix":"10.1186","volume":"8","author":[{"given":"Rosemary E","family":"Weir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Gorak-Stolinska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sian","family":"Floyd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maeve K","family":"Lalor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally","family":"Stenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith","family":"Branson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rose","family":"Blitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Ben-Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul EM","family":"Fine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hazel M","family":"Dockrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,1,25]]},"reference":[{"key":"600_CR1","volume-title":"Changes to the BCG vaccination programme. Professional Letter PL\/CMO\/2005\/3, PL\/CNO\/2005\/3, PL\/CPHO\/2005\/3.","author":"Department of Health","year":"2005","unstructured":"Department of Health: Changes to the BCG vaccination programme. Professional Letter PL\/CMO\/2005\/3, PL\/CNO\/2005\/3, PL\/CPHO\/2005\/3. 2005, Department of Health, London,, [http:\/\/www.dh.gov.uk\/en\/Publicationsandstatistics\/Lettersandcirculars\/Professionalletters\/Chiefnursingofficerletters\/DH_4114994]"},{"issue":"3","key":"600_CR2","first-page":"200","volume":"2","author":"JA Sterne","year":"1998","unstructured":"Sterne JA, Rodrigues LC, Guedes IN: Does the efficacy of BCG decline with time since vaccination?. Int J Tuberc Lung Dis. 1998, 2 (3): 200-207.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"10","key":"600_CR3","first-page":"1171","volume":"9","author":"ML Barreto","year":"2005","unstructured":"Barreto ML, Cunha SS, Pereira SM, Genser B, Hijjar MA, Yury Ichihara M, de Brito SC, Dourado I, Cruz A, Santa'Ana C, Rodrigues LC: Neonatal BCG protection against tuberculosis lasts for 20 years in Brazil. Int J Tuberc Lung Dis. 2005, 9 (10): 1171-1173.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"17","key":"600_CR4","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1001\/jama.291.17.2086","volume":"291","author":"NE Aronson","year":"2004","unstructured":"Aronson NE, Santosham M, Comstock GW, Howard RS, Moulton LH, Rhoades ER, Harrison LH: Long-term efficacy of BCG vaccine in American Indians and Alaska Natives: A 60-year follow-up study. Jama. 2004, 291 (17): 2086-2091. 10.1001\/jama.291.17.2086.","journal-title":"Jama"},{"issue":"6","key":"600_CR5","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1086\/342416","volume":"186","author":"S Floyd","year":"2002","unstructured":"Floyd S, Ponnighaus JM, Bliss L, Nkhosa P, Sichali L, Msiska G, Fine PE: Kinetics of delayed-type hypersensitivity to tuberculin induced by bacille Calmette-Guerin vaccination in northern Malawi. J Infect Dis. 2002, 186 (6): 807-814. 10.1086\/342416.","journal-title":"J Infect Dis"},{"issue":"9315","key":"600_CR6","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/S0140-6736(02)08353-8","volume":"359","author":"GF Black","year":"2002","unstructured":"Black GF, Weir RE, Floyd S, Bliss L, Warndorff DK, Crampin AC, Ngwira B, Sichali L, Nazareth B, Blackwell JM, Branson K, Chaguluka SD, Donovan L, Jarman E, King E, Fine PE, Dockrell HM: BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies. Lancet. 2002, 359 (9315): 1393-1401. 10.1016\/S0140-6736(02)08353-8.","journal-title":"Lancet"},{"issue":"2","key":"600_CR7","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/0041-3879(87)90023-7","volume":"68","author":"I Sutherland","year":"1987","unstructured":"Sutherland I, Springett VH: Effectiveness of BCG vaccination in England and Wales in 1983. Tubercle. 1987, 68 (2): 81-92. 10.1016\/0041-3879(87)90023-7.","journal-title":"Tubercle"},{"issue":"9019","key":"600_CR8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0140-6736(96)02166-6","volume":"348","author":"Karonga Prevention Trial Group","year":"1996","unstructured":"Karonga Prevention Trial Group: Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Karonga Prevention Trial Group. Lancet. 1996, 348 (9019): 17-24. 10.1016\/S0140-6736(96)02166-6.","journal-title":"Lancet"},{"issue":"1 Pt 1","key":"600_CR9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1542\/peds.96.1.29","volume":"96","author":"GA Colditz","year":"1995","unstructured":"Colditz GA, Berkey CS, Mosteller F, Brewer TF, Wilson ME, Burdick E, Fineberg HV: The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. Pediatrics. 1995, 96 (1 Pt 1): 29-35.","journal-title":"Pediatrics"},{"issue":"2","key":"600_CR10","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1046\/j.1365-2249.2003.02272","volume":"134","author":"RE Weir","year":"2003","unstructured":"Weir RE, Fine PE, Nazareth B, Floyd S, Black GF, King E, Stanley C, Bliss L, Branson K, Dockrell HM: Interferon-gamma and skin test responses of schoolchildren in southeast England to purified protein derivatives from Mycobacterium tuberculosis and other species of mycobacteria. Clin Exp Immunol. 2003, 134 (2): 285-294. 10.1046\/j.1365-2249.2003.02272.","journal-title":"Clin Exp Immunol"},{"issue":"29-30","key":"600_CR11","doi-asserted-by":"publisher","first-page":"5726","DOI":"10.1016\/j.vaccine.2006.04.037","volume":"24","author":"P Gorak-Stolinska","year":"2006","unstructured":"Gorak-Stolinska P, Weir RE, Floyd S, Lalor MK, Stenson S, Branson K, Blitz R, Luke S, Nazareth B, Ben-Smith A, Fine PE, Dockrell HM: Immunogenicity of Danish-SSI 1331 BCG vaccine in the UK: comparison with Glaxo-Evans 1077 BCG vaccine. Vaccine. 2006, 24 (29-30): 5726-5733. 10.1016\/j.vaccine.2006.04.037.","journal-title":"Vaccine"},{"key":"600_CR12","first-page":"231","volume-title":"Immunisation against infectious disease","author":"Department of Health","year":"1996","unstructured":"Department of Health: Tuberculosis: BCG Immunisation. Immunisation against infectious disease. Edited by: Salisbury DMBNT. 1996, London , HMSO, 231-232. 2","edition":"2"},{"issue":"3","key":"600_CR13","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1111\/j.1365-2249.2006.03222.x","volume":"146","author":"RE Weir","year":"2006","unstructured":"Weir RE, Black GF, Nazareth B, Floyd S, Stenson S, Stanley C, Branson K, Sichali L, Chaguluka SD, Donovan L, Crampin AC, Fine PE, Dockrell HM: The influence of previous exposure to environmental mycobacteria on the interferon-gamma response to bacille Calmette-Guerin vaccination in southern England and northern Malawi. Clin Exp Immunol. 2006, 146 (3): 390-399. 10.1111\/j.1365-2249.2006.03222.x.","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"600_CR14","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1086\/322042","volume":"184","author":"GF Black","year":"2001","unstructured":"Black GF, Dockrell HM, Crampin AC, Floyd S, Weir RE, Bliss L, Sichali L, Mwaungulu L, Kanyongoloka H, Ngwira B, Warndorff DK, Fine PE: Patterns and implications of naturally acquired immune responses to environmental and tuberculous mycobacterial antigens in northern Malawi. J Infect Dis. 2001, 184 (3): 322-329. 10.1086\/322042.","journal-title":"J Infect Dis"},{"issue":"11","key":"600_CR15","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1038\/nm1128","volume":"10","author":"H McShane","year":"2004","unstructured":"McShane H, Pathan AA, Sander CR, Keating SM, Gilbert SC, Huygen K, Fletcher HA, Hill AV: Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans. Nat Med. 2004, 10 (11): 1240-1244. 10.1038\/nm1128.","journal-title":"Nat Med"},{"issue":"2","key":"600_CR16","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1128\/IAI.70.2.672-678.2002","volume":"70","author":"L Brandt","year":"2002","unstructured":"Brandt L, Feino Cunha J, Weinreich Olsen A, Chilima B, Hirsch P, Appelberg R, Andersen P: Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis. Infect Immun. 2002, 70 (2): 672-678. 10.1128\/IAI.70.2.672-678.2002.","journal-title":"Infect Immun"},{"issue":"4","key":"600_CR17","first-page":"553","volume":"94","author":"CE Palmer","year":"1966","unstructured":"Palmer CE, Long MW: Effects of infection with atypical mycobacteria on BCG vaccination and tuberculosis. Am Rev Respir Dis. 1966, 94 (4): 553-568.","journal-title":"Am Rev Respir Dis"},{"issue":"7","key":"600_CR18","first-page":"788","volume":"11","author":"H Igari","year":"2007","unstructured":"Igari H, Watanabe A, Sato T: Booster phenomenon of QuantiFERON-TB Gold after prior intradermal PPD injection. Int J Tuberc Lung Dis. 2007, 11 (7): 788-791.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"11","key":"600_CR19","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1084\/jem.20032083","volume":"199","author":"B Combadiere","year":"2004","unstructured":"Combadiere B, Boissonnas A, Carcelain G, Lefranc E, Samri A, Bricaire F, Debre P, Autran B: Distinct time effects of vaccination on long-term proliferative and IFN-gamma-producing T cell memory to smallpox in humans. J Exp Med. 2004, 199 (11): 1585-1593. 10.1084\/jem.20032083.","journal-title":"J Exp Med"},{"issue":"8","key":"600_CR20","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nrmicro1211","volume":"3","author":"P Andersen","year":"2005","unstructured":"Andersen P, Doherty TM: The success and failure of BCG - implications for a novel tuberculosis vaccine. Nat Rev Microbiol. 2005, 3 (8): 656-662. 10.1038\/nrmicro1211.","journal-title":"Nat Rev Microbiol"},{"issue":"14","key":"600_CR21","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1016\/j.vaccine.2005.12.011","volume":"24","author":"AR Bennett","year":"2006","unstructured":"Bennett AR, Gorak-Stolinska P, Ben-Smith A, Floyd S, de Lara CM, Weir RE, Lalor MK, Makamo K, Msiska GK, Crampin AC, Fine PE, Dockrell HM, Beverley PC: The PPD-specific T-cell clonal response in UK and Malawian subjects following BCG vaccination: a new repertoire evolves over 12 months. Vaccine. 2006, 24 (14): 2617-2626. 10.1016\/j.vaccine.2005.12.011.","journal-title":"Vaccine"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-8-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-8-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-8-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-8-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T03:13:33Z","timestamp":1684206813000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-8-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,25]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["600"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-8-9","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,25]]},"assertion":[{"value":"22 August 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2008","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2008","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"9"}}